Lipo-Peptides/Saccharides for Peptide Vaccine Delivery

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/B978-0-12-385095-9.00078-6
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Lipid Peptide Core Nanoparticles as Multivalent Vaccine Candidates against Streptococcus pyogenes

  2012cited by this paper
• Self-adjuvanting polyacrylic nanoparticulate delivery system for group A streptococcus (GAS) vaccine.

  2011cited by this paper
• Modern lipid‐, carbohydrate‐, and peptide‐based delivery systems for peptide, vaccine, and gene products

  2011cited by this paper
• Lipid-core-peptide system for self-adjuvanting synthetic vaccine delivery.

  2011cited by this paper
• Peptide-based subunit nanovaccines.

  2011cited by this paper
• Group A Streptococcal Vaccine Candidates based on the Conserved Conformational Epitope from M Protein

  2011cited by this paper
• Design of three-component vaccines against group A streptococcal infections: importance of spatial arrangement of vaccine components.

  2010cited by this paper
• Toll-like receptor 2 mediated dendritic cell activation: Key target for lipopeptide vaccines design

  2010cited by this paper
• Targeting Toll-like receptors: emerging therapeutics?

  2010cited by this paper
• Structure-activity relationship of lipopeptide Group A streptococcus (GAS) vaccine candidates on toll-like receptor 2.

  2010cited by this paper
• Polyacrylate dendrimer nanoparticles: a self-adjuvanting vaccine delivery system.

  2010cited by this paper
• A novel synthetic adjuvant enhances dendritic cell function

  2009cited by this paper
• Lipid Core Peptide System for Gene, Drug, and Vaccine Delivery

  2009cited by this paper
• Structure-activity relationship of a series of synthetic lipopeptide self-adjuvanting group a streptococcal vaccine candidates.

  2008cited by this paper
• Development of a liposaccharide-based delivery system and its application to the design of group A streptococcal vaccines.

  2008cited by this paper
• Mannose-targeted systems for the delivery of therapeutics

  2008cited by this paper
• Self-adjuvanting lipopeptide vaccines.

  2008cited by this paper
• Synthesis and immunological evaluation of self-adjuvanting glycolipopeptide vaccine candidates.

  2008cited by this paper
• Enhanced protection against Streptococcus pyogenes infection by intranasal vaccination with a dual antigen component M protein/SfbI lipid core peptide vaccine formulation.

  2007cited by this paper
• Toward the development of prophylactic and therapeutic human papillomavirus type-16 lipopeptide vaccines.

  2007cited by this paper
• More than one reason to rethink the use of peptides in vaccine design

  2007cited by this paper
• Paclitaxel prodrugs: toward smarter delivery of anticancer agents.

  2006cited by this paper
• Intranasal administration is an effective mucosal vaccine delivery route for self-adjuvanting lipid core peptides targeting the group A streptococcal M protein.

  2006cited by this paper
• Method for the synthesis of multi-epitopic Streptococcus pyogenes lipopeptide vaccines using native chemical ligation.

  2006cited by this paper
• Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus.

  2006cited by this paper
• Synthesis of a highly pure lipid core peptide based self-adjuvanting triepitopic group A streptococcal vaccine, and subsequent immunological evaluation.

  2006cited by this paper
• Lipid-based self-adjuvanting vaccines.

  2005cited by this paper
• Toward the development of a synthetic group a streptococcal vaccine of high purity and broad protective coverage.

  2004cited by this paper
• Vaccine development for group A streptococcus infections and associated disease.

  2004cited by this paper
• Development of lipid-core-peptide (LCP) based vaccines for the prevention of group A streptococcal (GAS) infection

  2003cited by this paper
• Potential of Lipid Core Peptide Technology as a Novel Self-Adjuvanting Vaccine Delivery System for Multiple Different Synthetic Peptide Immunogens

  2003cited by this paper
• Development of lipid-core-peptide (LCP) based vaccines for the prevention of group A streptococcal (GAS) infection

  2003cited by this paper
• Lipoamino acid-based adjuvant carrier system: enhanced immunogenicity of group a streptococcal peptide epitopes.

  2002cited by this paper
• Enhancing the immunogenicity and modulating the fine epitope recognition of antisera to a helical group A streptococcal peptide vaccine candidate from the M protein using lipid‐core peptide technology

  2002cited by this paper
• Immunogenicity evaluation of a lipidic amino acid-based synthetic peptide vaccine for Chlamydia trachomatis.

  1993cited by this paper
• Lipidic peptides, I. Synthesis, resolution and structural elucidation of lipidic amino acids and their homo- and hetero-oligomers

  1990cited by this paper

• The bright side of chemistry: Exploring synthetic peptide‐based anticancer vaccines

  2024influential citation
• The influence of component structural arrangement on peptide vaccine immunogenicity.

  2022cites this paper
• Advances in Infectious Disease Vaccine Adjuvants

  2022cites this paper
• Dendrimers in vaccine delivery: Recent progress and advances.

  2021cites this paper
• Poly(hydrophobic amino acid) Conjugates for the Delivery of Multiepitope Vaccine against Group A Streptococcus.

  2021cites this paper
• A nanovaccine formulation of Chlamydia recombinant MOMP encapsulated in PLGA 85:15 nanoparticles augments CD4+ effector (CD44high CD62Llow) and memory (CD44high CD62Lhigh) T-cells in immunized mice.

  2020cites this paper
• Carbohydrate Immune Adjuvants in Subunit Vaccines

  2020influential citation
• Recent Advances in the Development of Peptide Vaccines and Their Delivery Systems against Group A Streptococcus

  2019influential citation
• Structure-activity relationship of group A streptococcus lipopeptide vaccine candidates in trimethyl chitosan-based self-adjuvanting delivery system.

  2019cites this paper
• Cholic Acid-based Delivery System for Vaccine Candidates against Group A Streptococcus.

  2019cites this paper
• Peptide-based vaccines

  2018cites this paper
• Influence of Physicochemical Properties of Lipopeptide Adjuvants on the Immune Response: A Rationale for Engineering a Potent Vaccine.

  2018cites this paper
• Lipids as activators of innate immunity in peptide vaccine delivery.

  2018cites this paper
• Induction of high titred, non-neutralising antibodies by self-adjuvanting peptide epitopes derived from the respiratory syncytial virus fusion protein

  2017cites this paper
• Recent advances in self‐assembled peptides: Implications for targeted drug delivery and vaccine engineering

  2017cites this paper
• Intranasal delivery of nanoparticle-based vaccines.

  2017cites this paper
• Bivalent mucosal peptide vaccines administered using the LCP carrier system stimulate protective immune responses against Streptococcus pyogenes infection.

  2017cites this paper
• Synthesis of Mannosylated Lipopeptides with Receptor Targeting Properties.

  2016cites this paper
• The Use of Microwave-Assisted Solid-Phase Peptide Synthesis and Click Chemistry for the Synthesis of Vaccine Candidates Against Hookworm Infection.

  2016cites this paper
• Recent progress in adjuvant discovery for peptide-based subunit vaccines

  2014cites this paper
• Toll-like receptor agonists: a patent review (2011 – 2013)

  2014cites this paper
• Recent advances in peptide-based subunit nanovaccines.

  2014cites this paper
• triggered peptide self-assembly into fibrils : a potential peptide-based subunit vaccine delivery platform Biochemical Compounds

  2013cites this paper
• pH-Triggered peptide self-assembly into fibrils: a potential peptide-based subunit vaccine delivery platform

  2013cites this paper
• M-protein-derived conformational peptide epitope vaccine candidate against Group A Streptococcus.

  2013cites this paper
• Vaccination with Lipid Core Peptides Fails to Induce Epitope-Specific T Cell Responses but Confers Non-Specific Protective Immunity in a Malaria Model

  2012cites this paper